Ortivus AB (publ) (ORTI-B.ST)
SEK 1.4
(-2.32%)
SEK 1.4
(-2.32%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 5.48 Million SEK | -11.88% |
| 2022 | 6.22 Million SEK | 87.92% |
| 2021 | 3.31 Million SEK | 228.37% |
| 2020 | 1 Million SEK | -68.31% |
| 2019 | 3.18 Million SEK | -75.58% |
| 2018 | 13.02 Million SEK | 29.73% |
| 2017 | 10.03 Million SEK | -49.98% |
| 2016 | 20.07 Million SEK | -16.66% |
| 2015 | 24.08 Million SEK | 294.75% |
| 2014 | 6.1 Million SEK | 0.0% |
| 2013 | - SEK | 0.0% |
| 2012 | - SEK | 0.0% |
| 2011 | - SEK | 0.0% |
| 2010 | - SEK | -100.0% |
| 2009 | 28.75 Million SEK | -0.19% |
| 2008 | 28.8 Million SEK | 33.85% |
| 2007 | 21.52 Million SEK | -38.84% |
| 2006 | 35.18 Million SEK | -8.94% |
| 2005 | 38.64 Million SEK | 0.0% |
| 2004 | - SEK | 0.0% |
| 2003 | - SEK | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 13.02 Million SEK | 137.55% |
| 2024 Q2 | 19.85 Million SEK | 52.46% |
| 2023 Q3 | 23.13 Million SEK | 235.4% |
| 2023 FY | 5.48 Million SEK | -11.88% |
| 2023 Q2 | 6.89 Million SEK | -14.29% |
| 2023 Q1 | 8.04 Million SEK | 29.41% |
| 2023 Q4 | 5.48 Million SEK | -76.31% |
| 2022 FY | 6.22 Million SEK | 87.92% |
| 2022 Q4 | 6.22 Million SEK | 106.17% |
| 2022 Q2 | 3.01 Million SEK | 0.0% |
| 2022 Q1 | 3.01 Million SEK | -8.82% |
| 2022 Q3 | 3.01 Million SEK | -0.03% |
| 2021 FY | 3.31 Million SEK | 228.37% |
| 2021 Q2 | 2.98 Million SEK | 12.33% |
| 2021 Q4 | 3.31 Million SEK | 23.09% |
| 2021 Q3 | 2.68 Million SEK | -10.01% |
| 2021 Q1 | 2.66 Million SEK | 163.89% |
| 2020 Q3 | 1.29 Million SEK | -17.78% |
| 2020 Q4 | 1 Million SEK | -21.86% |
| 2020 Q1 | 1.85 Million SEK | -41.62% |
| 2020 Q2 | 1.56 Million SEK | -15.51% |
| 2020 FY | 1 Million SEK | -68.31% |
| 2019 Q3 | 5.65 Million SEK | 136.6% |
| 2019 FY | 3.18 Million SEK | -75.58% |
| 2019 Q1 | 13.28 Million SEK | 1.97% |
| 2019 Q2 | 2.39 Million SEK | -82.0% |
| 2019 Q4 | 3.18 Million SEK | -43.77% |
| 2018 Q4 | 13.02 Million SEK | 11.76% |
| 2018 Q2 | 10.15 Million SEK | 753.11% |
| 2018 FY | 13.02 Million SEK | 29.73% |
| 2018 Q1 | 1.19 Million SEK | -88.15% |
| 2018 Q3 | 11.65 Million SEK | 14.8% |
| 2017 Q4 | 10.03 Million SEK | 0.0% |
| 2017 Q1 | 800 Thousand SEK | -96.01% |
| 2017 FY | 10.03 Million SEK | -49.98% |
| 2017 Q2 | 200 Thousand SEK | -75.0% |
| 2017 Q3 | - SEK | -100.0% |
| 2016 Q4 | 20.07 Million SEK | 346.02% |
| 2016 FY | 20.07 Million SEK | -16.66% |
| 2016 Q2 | 4.3 Million SEK | -20.37% |
| 2016 Q1 | 5.4 Million SEK | -77.58% |
| 2016 Q3 | 4.5 Million SEK | 4.65% |
| 2015 Q1 | 515 Thousand SEK | -91.56% |
| 2015 FY | 24.08 Million SEK | 294.75% |
| 2015 Q3 | 8.88 Million SEK | -11.8% |
| 2015 Q4 | 24.08 Million SEK | 171.09% |
| 2015 Q2 | 10.07 Million SEK | 1855.92% |
| 2014 Q4 | 6.1 Million SEK | 0.0% |
| 2014 Q2 | - SEK | 0.0% |
| 2014 FY | 6.1 Million SEK | 0.0% |
| 2014 Q3 | - SEK | 0.0% |
| 2014 Q1 | - SEK | 0.0% |
| 2013 Q4 | - SEK | 0.0% |
| 2013 Q1 | - SEK | 0.0% |
| 2013 Q2 | - SEK | 0.0% |
| 2013 FY | - SEK | 0.0% |
| 2013 Q3 | - SEK | 0.0% |
| 2012 FY | - SEK | 0.0% |
| 2012 Q1 | - SEK | 0.0% |
| 2012 Q2 | - SEK | 0.0% |
| 2012 Q3 | - SEK | 0.0% |
| 2012 Q4 | - SEK | 0.0% |
| 2011 Q3 | - SEK | 0.0% |
| 2011 FY | - SEK | 0.0% |
| 2011 Q1 | - SEK | 0.0% |
| 2011 Q2 | - SEK | 0.0% |
| 2011 Q4 | - SEK | 0.0% |
| 2010 Q4 | - SEK | 0.0% |
| 2010 FY | - SEK | -100.0% |
| 2009 FY | 28.75 Million SEK | -0.19% |
| 2008 FY | 28.8 Million SEK | 33.85% |
| 2007 FY | 21.52 Million SEK | -38.84% |
| 2006 FY | 35.18 Million SEK | -8.94% |
| 2005 FY | 38.64 Million SEK | 0.0% |
| 2004 FY | - SEK | 0.0% |
| 2003 FY | - SEK | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| AddLife AB (publ) | 5.28 Billion SEK | 99.896% |
| Biotage AB (publ) | 150 Million SEK | 96.346% |
| Bonesupport Holding AB (publ) | 17.48 Million SEK | 68.651% |
| Doxa AB (publ) | 9.7 Million SEK | 43.495% |
| Elekta AB (publ) | 7.24 Billion SEK | 99.924% |
| iZafe Group AB (publ) | 3.17 Million SEK | -72.63% |
| Ortivus AB (publ) | 5.48 Million SEK | 0.0% |
| Q-linea AB (publ) | 20.56 Million SEK | 73.348% |
| S2Medical AB (publ) | - SEK | -Infinity% |
| Synsam AB (publ) | 3.25 Billion SEK | 99.832% |